We are live on ! Find out more
VIA

Vident Investment Advisory Portfolio holdings

AUM $2.9B
1-Year Est. Return 24.67%
This Fund
S&P 500
This Quarter Est. Return
+5.44%
1 Year Est. Return
+24.67%
3 Year Est. Return
+82.63%
5 Year Est. Return
+113.33%
10 Year Est. Return
AUM
$2.22B
AUM Growth
+$375M
Cap. Flow
+$293M
Cap. Flow %
13.2%
Top 10 Hldgs %
17.55%
Holding
845
New
119
Increased
485
Reduced
177
Closed
64

Top Sells

Rank Stock Value
1
NOC icon
Northrop Grumman
NOC
+$14.9M
2
FTI icon
TechnipFMC
FTI
+$13.5M
3
ARAY icon
Accuray
ARAY
+$10.8M
4
IMMR icon
Immersion
IMMR
+$8.19M
5
XONE
The ExOne Company
XONE
+$4.9M

Sector Composition

Rank Sector Weight
1 Technology 25.66%
2 Industrials 13.74%
3 Healthcare 10.47%
4 Consumer Discretionary 8.12%
5 Financials 7.3%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
CBOE icon
376
Cboe Global Markets
CBOE
$30.2B
$1M 0.05%
8,026
-1,632
-17% -$191K
CL icon
377
Colgate-Palmolive
CL
$74.1B
$998K 0.04%
13,231
+1,440
+12% +$105K
LLY icon
378
Eli Lilly
LLY
$1.06T
$992K 0.04%
11,755
-2,957
-20% -$252K
CNDT icon
379
Conduent
CNDT
$271M
$991K 0.04%
61,339
+6,167
+11% +$96.5K
CMS icon
380
CMS Energy
CMS
$22.3B
$981K 0.04%
20,744
+3,748
+22% +$182K
BDX icon
381
Becton Dickinson
BDX
$48.8B
$971K 0.04%
4,649
+1,248
+37% +$261K
ALXN
382
DELISTED
Alexion Pharmaceuticals
ALXN
$966K 0.04%
8,082
+17
+0.2% +$2.07K
SIX
383
DELISTED
Six Flags Entertainment Corp.
SIX
$956K 0.04%
14,359
+6,330
+79% +$405K
NKE icon
384
Nike
NKE
$62.3B
$948K 0.04%
15,150
+416
+3% +$23.9K
AXE
385
DELISTED
Anixter International Inc
AXE
$948K 0.04%
12,469
+759
+6% +$55.9K
TECH icon
386
Bio-Techne
TECH
$11.2B
$937K 0.04%
28,940
+12,720
+78% +$404K
D icon
387
Dominion Energy
D
$58.8B
$905K 0.04%
11,161
+1,510
+16% +$122K
CF icon
388
CF Industries
CF
$17.9B
$904K 0.04%
21,254
-1,794
-8% -$67.7K
CRI icon
389
Carter's
CRI
$1.48B
$903K 0.04%
7,689
+3,490
+83% +$361K
SON icon
390
Sonoco
SON
$5.64B
$897K 0.04%
16,884
+7,440
+79% +$389K
MON
391
DELISTED
Monsanto Co
MON
$886K 0.04%
7,588
-1,141
-13% -$136K
OLN icon
392
Olin
OLN
$2.14B
$880K 0.04%
24,726
+10,890
+79% +$387K
MMM icon
393
3M
MMM
$93.2B
$877K 0.04%
4,459
-184
-4% -$35.4K
GAP
394
The Gap Inc
GAP
$7.39B
$868K 0.04%
25,505
-3,544
-12% -$106K
AGN
395
DELISTED
Allergan plc
AGN
$868K 0.04%
5,305
-747
-12% -$134K
CSL icon
396
Carlisle Companies
CSL
$15.2B
$865K 0.04%
7,607
+3,398
+81% +$371K
GLPI icon
397
Gaming and Leisure Properties
GLPI
$12.8B
$863K 0.04%
23,335
+9,879
+73% +$360K
CPRI icon
398
Capri Holdings
CPRI
$1.72B
$856K 0.04%
13,594
-1,112
-8% -$60.9K
CVX icon
399
Chevron
CVX
$371B
$851K 0.04%
6,804
+1,146
+20% +$136K
OPLN
400
Openlane
OPLN
$4.62B
$849K 0.04%
44,388
+19,799
+81% +$367K

Similar funds

Vident Investment Advisory's Q4 2017 Portfolio in Review

As of Q4 2017, Vident Investment Advisory held 845 positions worth $2.22B, up 20% from $1.85B the previous quarter. Its ten largest holdings account for 18% of the portfolio.

Vident Investment Advisory deployed $293M of net new capital in Q4 2017, opening 119 new positions and adding to 485 existing holdings. Its largest new stake was Novanta: 388,786 shares worth $19.4M.

By sector, the portfolio is most concentrated in Technology at 26% of assets, up from 23% a quarter earlier, followed by Industrials and Healthcare.

On the sell side, the largest reduction was Northrop Grumman, an estimated $14.9M trimmed.

  • Vident Investment Advisory's largest Q4 2017 buy was Novanta: 388,786 shares worth $19.4M.
  • Vident Investment Advisory added most to iRobot in Q4 2017, an estimated $18.1M increase.
  • Vident Investment Advisory's biggest Q4 2017 reduction was Northrop Grumman, cutting an estimated $14.9M.
  • Vident Investment Advisory fully exited TechnipFMC in Q4 2017, selling an estimated $13.5M.
  • Vident Investment Advisory's ten largest holdings make up 18% of its $2.22B portfolio in Q4 2017.
  • Vident Investment Advisory opened 119 new positions and closed 64 in Q4 2017.
  • Vident Investment Advisory's portfolio value rose 20% quarter-over-quarter to $2.22B.

Based on Vident Investment Advisory's 13F filing for Q4 2017, filed 15 Feb 2018.